Literature DB >> 480834

[Combined use of computerized tomography and echography in ophthalmology (author's transl)].

F Bigar, H Spiess, H U Gruber.   

Abstract

Computerized tomography does not give as fine an information as echography in the presence of intraocular changes, such as retinal detachments, organized vitreous hemorrhages or the differentiation of a choroidal prominence. Complementary computerized tomography, however, can be helpful in the presence of unclear echographic results in opaque media. Furthermore, an analysis of the value of computerized tomography and echography for the evaluation of orbital lesions is presented based mainly on the results of the preoperative tissue diagnosis in 31 histological proven lesions. The results show that a complementary CT-scan is not necessary in orbital lesions of the anterior third when a clear echographic tissue diagnosis exists. In lesions of the middle third of the orbit, echography and CT complement each other. For lesions situated within the orbital apex or for those which are in connection with adjacent structures, such as the intracranial space or the periorbital region, computerized tomography is superior and of a greater help than standardized A-scan echography aided by contact B-scan.

Entities:  

Mesh:

Year:  1979        PMID: 480834

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Sonography and computed tomography in the diagnosis of orbitocranial malformations and tumors.

Authors:  W Lieb; R Rochels; K Kretzschmar
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

2.  CT of the orbit: current status with high resolution computed tomography.

Authors:  G Wilms; J Smits; A L Baert
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

3.  CT of malignant choroidal melanoma - morphology and perfusion characteristics.

Authors:  M Heller; R Guthoff; J Hagemann; H H Jend
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.